Jason Amello, Chief Financial Officer at Candel Therapeutics, Inc. (CADL), bought 5,568 shares at $1.93 ($10K) on 2022-12-09, disclosed to the SEC on 2022-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.69 | 3,100 | $5K | 52.4% |
| 2 | $1.93 | 2,468 | $5K | 47.6% |
| Total | $1.80 avg | 5,568 | $10K | 100% |
| Filing → |
| AKBA | BUY | 2014-03-27 | $68K | — | Filing → |
| GENZ | SELL | 2010-09-02 | $467K | — | Filing → |
| GENZ | SELL | 2010-05-26 | $24K | — | Filing → |